Table 1 Clinical characteristics of the 271 patients with adnexal masses.
From: Nucleosome footprinting in plasma cell-free DNA for the pre-surgical diagnosis of ovarian cancer
Patients with an adnexal mass | ||||
|---|---|---|---|---|
(n = 271) | ||||
Benign mass | Borderline carcinoma | Invasive carcinoma | Metastatic tumor | |
(n = 130) | (n = 41) | (n = 92) | (n = 8) | |
Age (in years) | ||||
Median | 53 | 52 | 64 | 55 |
IQR | 43–64 | 37–63 | 57–73 | 52–69 |
Adnexal histology | ||||
Benign | ||||
Cystadenoma | 21 | – | – | – |
Cystadenofibroma | 52 | – | – | – |
Fibrothecoma | 1 | – | – | – |
Teratoma | 25 | – | – | – |
Leiomyoma | 13 | – | – | – |
Other | 18 | – | – | – |
Borderline | ||||
Serous | – | 22 | – | – |
Mucinous | – | 15 | – | – |
Other | – | 4 | – | – |
Invasive | ||||
High-grade serous | – | – | 62 | – |
Low-grade serous | – | – | 6 | – |
Mucinous | – | – | 8 | – |
Endometrioid | – | – | 9 | – |
Clear-cell | – | – | 3 | – |
Non-epithelial | – | – | 4 | – |
Metastasis | ||||
Gastric cancer | – | – | – | 3 |
Other | – | – | – | 5 |
FIGO stage | ||||
IA | – | 30 | 15 | – |
IB | – | 3 | – | – |
IC | – | 3 | 8 | – |
IIA | – | 1 | 1 | – |
IIB | – | 1 | 2 | – |
IIIA | – | 2 | 4 | – |
IIIB | – | 1 | 8 | – |
IIIC | – | – | 22 | – |
IVB | – | – | 32 | – |
CA-125 (in kU/L) | ||||
Median | 20 | 30 | 206 | 37 |
IQR | 12–34 | 18–109 | 63–643 | 23–91 |
